(Q44514078)

3 December 2017

title

Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis (English)

1 reference

3 December 2017

main subject

hepatocellular carcinoma

1 reference

Jia Fu

1

1 reference

3 December 2017

Huijuan Qiu

2

1 reference

3 December 2017

Muyan Cai

3

1 reference

3 December 2017

Yinghua Pan

4

1 reference

3 December 2017

Yun Cao

5

1 reference

3 December 2017

Lili Liu

6

1 reference

3 December 2017

Jingping Yun

7

1 reference

3 December 2017

Chris Zhiyi Zhang

8

1 reference

3 December 2017

publication date

17 February 2013

1 reference

3 December 2017

1 reference

3 December 2017

volume

104

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

508-515

1 reference

3 December 2017

cites work

Global cancer statistics

1 reference

Time trends in incidence and prognosis of primary liver cancer and liver metastases of unknown origin in a Danish region, 1985-2004.

21 January 2018

1 reference

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.

21 January 2018

1 reference

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.

21 January 2018

1 reference

Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.

21 January 2018

1 reference

Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates

21 January 2018

1 reference

Regulation of CDK/cyclin complexes during the cell cycle

21 January 2018

1 reference

Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins

21 January 2018

1 reference

Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction

21 January 2018

1 reference

SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation

21 January 2018

1 reference

Global identification of modular cullin-RING ligase substrates

21 January 2018

1 reference

Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair

21 January 2018

1 reference

Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis

21 January 2018

1 reference

Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.

21 January 2018

1 reference

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

21 January 2018

1 reference

Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma.

21 January 2018

1 reference

Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE).

21 January 2018

1 reference

High cyclin B1 expression is associated with poor survival in breast cancer

21 January 2018

1 reference

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

21 January 2018

1 reference

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

21 January 2018

1 reference

Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis?

21 January 2018

1 reference

Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis

21 January 2018

1 reference

Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding.

21 January 2018

1 reference

The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1.

21 January 2018

1 reference

Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection

21 January 2018

1 reference

Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.

21 January 2018

1 reference

Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer

21 January 2018

1 reference

A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.

21 January 2018

1 reference

Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma

21 January 2018

1 reference

Down-regulation of cyclin F levels during nerve growth factor-induced differentiation of PC12 cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23305207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The relationship between Cyclin G1 and survival in patients treated surgically for HCC.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23305207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/23305207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CAS.12100

1 reference

3 December 2017

0 references

1 reference